Roche Accelerator was honored on Wednesday with the 2021 Award for Innovation in Social Governance, an accolade organized by Shanghai Daily under the guidance of the Information Office of Shanghai Municipality and Shanghai United Media Group. This award honors enterprises for outstanding contributions to economic growth and social governance through innovative practice in line with Shanghai’s ambition to build a “science and technology innovation center with global influence.” It also encourages multinational companies to explore new solutions to jointly bolster community development. The Swiss healthcare giant’s Roche Accelerator stood out to win the award from among 500 Chinese and foreign multinational corporations. The accelerator was officially launched in 2021 with the backing of government and strategic partners who invested nearly 300 million yuan (USD 47.3 million). As Roche’s first in-house accelerator worldwide, it aims to stimulate healthcare innovation in China and empower the local primary care ecosystem. It focuses on pharma, diagnostics, and personalized healthcare, including artificial intelligence (AI), digital solutions, and other frontier medical fields. Led by Roche R&D, it leverages the firm’s full-spectrum resources, ranging from early research and development to commercialization. It also works with partners to provide promising innovative startups with space, technology guidance, funding and operational support to reduce research risk, and foster scientific achievement.